Product Name :
Azaphen
Description:
Pipofezine, also known as Azafen or Azaphen, is a tricyclic antidepressant (TCA) approved in Russia for the treatment of depression. It was introduced in the late 1960s and is still used today. Pipofezine has been shown to act as a potent inhibitor of the reuptake of serotonin. In addition to its antidepressant action, pipofezine has sedative effects as well, suggesting antihistamine activity. Other properties such as anticholinergic or antiadrenergic actions are less clear but are likely.
CAS:
24853-80-3
Molecular Weight:
370.28
Formula:
C16H21Cl2N5O
Chemical Name:
9-methyl-6-(4-methylpiperazin-1-yl)-2-oxa-4,5,9-triazatricyclo[8.4.0.0³,⁸]tetradeca-1(14),3,5,7,10,12-hexaene dihydrochloride
Smiles :
Cl.Cl.CN1CCN(CC1)C1=CC2=C(N=N1)OC1=CC=CC=C1N2C
InChiKey:
ZZVWCKAYZSAUKR-UHFFFAOYSA-N
InChi :
InChI=1S/C16H19N5O.2ClH/c1-19-7-9-21(10-8-19)15-11-13-16(18-17-15)22-14-6-4-3-5-12(14)20(13)2;;/h3-6,11H,7-10H2,1-2H3;2*1H
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥360 days if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Pipofezine, also known as Azafen or Azaphen, is a tricyclic antidepressant (TCA) approved in Russia for the treatment of depression.{{M‑89} web|{M‑89} Epigenetics|{M‑89} Protocol|{M‑89} Data Sheet|{M‑89} manufacturer|{M‑89} Cancer} It was introduced in the late 1960s and is still used today.{{Sotagliflozin} web|{Sotagliflozin} SGLT|{Sotagliflozin} Protocol|{Sotagliflozin} In stock|{Sotagliflozin} manufacturer|{Sotagliflozin} Epigenetic Reader Domain} Pipofezine has been shown to act as a potent inhibitor of the reuptake of serotonin. In addition to its antidepressant action, pipofezine has sedative effects as well, suggesting antihistamine activity. Other properties such as anticholinergic or antiadrenergic actions are less clear but are likely.|Product information|CAS Number: 24853-80-3|Molecular Weight: 370.PMID:24463635 28|Formula: C16H21Cl2N5O|Chemical Name: 9-methyl-6-(4-methylpiperazin-1-yl)-2-oxa-4,5,9-triazatricyclo[8.4.0.0³,⁸]tetradeca-1(14),3,5,7,10,12-hexaene dihydrochloride|Smiles: Cl.Cl.CN1CCN(CC1)C1=CC2=C(N=N1)OC1=CC=CC=C1N2C|InChiKey: ZZVWCKAYZSAUKR-UHFFFAOYSA-N|InChi: InChI=1S/C16H19N5O.2ClH/c1-19-7-9-21(10-8-19)15-11-13-16(18-17-15)22-14-6-4-3-5-12(14)20(13)2;;/h3-6,11H,7-10H2,1-2H3;2*1H|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥360 days if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|Products are for research use only. Not for human use.|